These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 28557738

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thrombotic risk associated with gender-affirming hormone therapy.
    Mullins TLK, Mullins ES.
    J Thromb Haemost; 2024 Aug; 22(8):2129-2139. PubMed ID: 38795871
    [Abstract] [Full Text] [Related]

  • 7. Physiologic Response to Gender-Affirming Hormones Among Transgender Youth.
    Olson-Kennedy J, Okonta V, Clark LF, Belzer M.
    J Adolesc Health; 2018 Apr; 62(4):397-401. PubMed ID: 29056436
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reference Intervals for Clinical Chemistry Analytes for Transgender Men and Women on Stable Hormone Therapy.
    Humble RM, Greene DN, Schmidt RL, Winston McPherson G, Rongitsch J, Imborek KL, Nisly N, Dole NJ, Dane SK, Frerichs J, Krasowski MD.
    J Appl Lab Med; 2022 Sep 01; 7(5):1131-1144. PubMed ID: 35584132
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals.
    Mueller A, Haeberle L, Zollver H, Claassen T, Kronawitter D, Oppelt PG, Cupisti S, Beckmann MW, Dittrich R.
    J Sex Med; 2010 Sep 01; 7(9):3190-8. PubMed ID: 20584125
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of sex steroids on the pattern of methylation and expression of the promoter region of estrogen and androgen receptors in people with gender dysphoria under cross-sex hormone treatment.
    Aranda G, Fernández-Rebollo E, Pradas-Juni M, Hanzu FA, Kalko SG, Halperin I, Mora M.
    J Steroid Biochem Mol Biol; 2017 Sep 01; 172():20-28. PubMed ID: 28539237
    [Abstract] [Full Text] [Related]

  • 19. Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis.
    Tack LJ, Craen M, Dhondt K, Vanden Bossche H, Laridaen J, Cools M.
    Biol Sex Differ; 2016 Sep 01; 7():14. PubMed ID: 26885361
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.